These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23472268)

  • 1. The cost (and quality) of health care.
    Neumann ME
    Nephrol News Issues; 2013 Feb; 27(2):12. PubMed ID: 23472268
    [No Abstract]   [Full Text] [Related]  

  • 2. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 3. Bundling and its potential impact on dialysis service providers.
    Sullivan J
    Nephrol News Issues; 2008 Oct; 22(11):12, 14, 16-7. PubMed ID: 19009855
    [No Abstract]   [Full Text] [Related]  

  • 4. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

  • 5. Adapting to changes in Medicare cost report requirements.
    Rossi T
    Nephrol News Issues; 2005 Sep; 19(10):36-9. PubMed ID: 16187645
    [No Abstract]   [Full Text] [Related]  

  • 6. The 2011 ESRD prospective payment system: welcome to the bundle.
    Weiner DE
    Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
    [No Abstract]   [Full Text] [Related]  

  • 7. The 2011 ESRD prospective payment system: an uncontrolled experiment.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
    [No Abstract]   [Full Text] [Related]  

  • 8. The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.
    Bhat P; Bhat JG
    Am J Kidney Dis; 2011 Apr; 57(4):556-8. PubMed ID: 21316132
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
    [No Abstract]   [Full Text] [Related]  

  • 10. The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.
    Johnson DS; Meyer KB; Johnson HK
    Am J Kidney Dis; 2011 Apr; 57(4):553-5. PubMed ID: 21333427
    [No Abstract]   [Full Text] [Related]  

  • 11. The morbidity and cost implications of hemodialysis clinical performance measures.
    O'Connor AS; Wish JB; Sehgal AR
    Hemodial Int; 2005 Oct; 9(4):349-61. PubMed ID: 16219055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it time for Medicare to provide reimbursement for daily hemodialysis?
    Newmann JM
    Nephrol News Issues; 2001 Apr; 15(5):57-9. PubMed ID: 12108965
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost functions for dialysis facilities and the quality of dialysis.
    Escarce JJ; Feldman HI
    Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497
    [No Abstract]   [Full Text] [Related]  

  • 14. Squeezing more cost and care out of dialysis: our patients would pay the price.
    Meyer KB; Kassirer JP
    Am J Med; 2002 Feb; 112(3):232-4. PubMed ID: 11893351
    [No Abstract]   [Full Text] [Related]  

  • 15. ESRD data system needs a fix. Lack of updates impacts beneficiaries, costs Medicare; USRDS looks elsewhere for accurate data.
    Nephrol News Issues; 2002 Apr; 16(5):8, 10. PubMed ID: 11962159
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of anti-fraud enforcement on Medicare costs and quality.
    Natl Bur Econ Res Bull Aging Health; 2004; (9):3. PubMed ID: 15580713
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of the Medicare cost report.
    Bednar B
    ANNA J; 1992 Jun; 19(3):235. PubMed ID: 1627002
    [No Abstract]   [Full Text] [Related]  

  • 18. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions for coverage fail to relieve administrative burden.
    Wish D
    Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
    [No Abstract]   [Full Text] [Related]  

  • 20. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.